{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:22:26Z","timestamp":1774009346028,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:00:00Z","timestamp":1434672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:00:00Z","timestamp":1434672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adult T-cell leukaemia\/lymphoma (ATL) is an aggressive T-cell malignancy that develops after long-term infection with human T-cell leukaemia virus (HTLV)-1. The identification of new molecular targets for ATL prevention and treatment is desired. SIRT1, a nicotinamide adenine dinucleotide<jats:sup>+<\/jats:sup> -dependent histone\/protein deacetylase, plays crucial roles in various physiological processes, including aging and apoptosis. We previously reported that ATL patients had significantly higher SIRT1 protein levels than healthy controls. Here, we demonstrate that two novel small-molecule SIRT1 inhibitors, NCO-01\/04, reduced cell viability and enhanced apoptotic cells in peripheral blood monocyte cells of patients with acute ATL, which has a poor prognosis. NCO-01\/04 also reduced the cell viability with DNA fragmentation, Annexin V-positive cells and caspase activation. However, a caspase inhibitor did not inhibit this caspase-dependent cell death. NCO-01\/04 enhanced the endonuclease G level in the nucleus with loss of the mitochondrial transmembrane potential, which can promote caspase-independent death. Interestingly, NCO-01\/04 increased the LC3-II-enriched protein fraction, indicating autophagosome accumulation as well as autophagy. Thus, NCO-01\/04 simultaneously caused caspase activation and autophagy. These results suggest that NCO-01\/04 is highly effective against ATL cells in caspase-dependent or -independent manners with autophagy and that its clinical application might improve the prognosis of patients with this fatal disease.<\/jats:p>","DOI":"10.1038\/srep11345","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T13:39:43Z","timestamp":1434721183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells"],"prefix":"10.1038","volume":"5","author":[{"given":"Tomohiro","family":"Kozako","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomichi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"BFsrep11345_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","volume":"15","author":"T Uchiyama","year":"1997","unstructured":"Uchiyama, T. Human T cell leukemia virus type I (HTLV-I) and human diseases. in Annu Rev Immunol, 15, 15\u201337 (1997).","journal-title":"Annu Rev Immunol"},{"key":"BFsrep11345_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck, K. et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7, 266\u2013281 (2007).","journal-title":"Lancet Infect Dis"},{"key":"BFsrep11345_CR3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","volume":"19","author":"M Yoshida","year":"2001","unstructured":"Yoshida, M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19, 475\u2013496 (2001).","journal-title":"Annu Rev Immunol"},{"key":"BFsrep11345_CR4","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","volume":"177","author":"T Kozako","year":"2006","unstructured":"Kozako, T. et al. Reduced frequency, diversity and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol 177, 5718\u20135726 (2006).","journal-title":"J Immunol"},{"key":"BFsrep11345_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","volume":"23","author":"T Kozako","year":"2009","unstructured":"Kozako, T. et al. PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients. Leukemia 23, 375\u2013382 (2009).","journal-title":"Leukemia"},{"key":"BFsrep11345_CR6","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor, G. P. & Matsuoka, M. Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene 24, 6047\u20136057 (2005).","journal-title":"Oncogene"},{"key":"BFsrep11345_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka, M. & Jeang, K. T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7, 270\u2013280 (2007).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep11345_CR8","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki, K. et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25, 5458\u20135464 (2007).","journal-title":"J Clin Oncol"},{"key":"BFsrep11345_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada, Y. et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113, 375\u2013382 (2001).","journal-title":"Br J Haematol"},{"key":"BFsrep11345_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-642-38965-8_12","volume":"193","author":"M Yoshimitsu","year":"2014","unstructured":"Yoshimitsu, M., White, Y. & Arima, N. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia\/lymphoma. Recent Results Cancer Res 193, 211\u2013225 (2014).","journal-title":"Recent Results Cancer Res"},{"key":"BFsrep11345_CR11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molimm.2009.09.006","volume":"47","author":"T Kozako","year":"2009","unstructured":"Kozako, T. et al. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia. Mol Immunol 47, 606\u2013613 (2009).","journal-title":"Mol Immunol"},{"key":"BFsrep11345_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki, K. et al. Definition, prognostic factors, treatment and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27, 453\u2013459 (2009).","journal-title":"J Clin Oncol"},{"key":"BFsrep11345_CR13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrm1616","volume":"6","author":"L Bordone","year":"2005","unstructured":"Bordone, L. & Guarente, L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6, 298\u2013305 (2005).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep11345_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","volume":"404","author":"S Michan","year":"2007","unstructured":"Michan, S. & Sinclair, D. Sirtuins in mammals: insights into their biological function. Biochem J 404, 1\u201313 (2007).","journal-title":"Biochem J"},{"key":"BFsrep11345_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7150\/ijbs.5.147","volume":"5","author":"CX Deng","year":"2009","unstructured":"Deng, C. X. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 5, 147\u2013152 (2009).","journal-title":"Int J Biol Sci"},{"key":"BFsrep11345_CR16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1248\/yakushi.131.1061","volume":"131","author":"T Kozako","year":"2011","unstructured":"Kozako, T. New Strategy of Adult T-cell Leukemia Treatment Targeted for Anti-tumor Immunity and a Longevity Gene-encoded Protein. Yakugaku Zasshi 131, 1061\u20131072 (2011).","journal-title":"Yakugaku Zasshi"},{"key":"BFsrep11345_CR17","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/ijc.27481","volume":"131","author":"T Kozako","year":"2012","unstructured":"Kozako, T. et al. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer 131, 2044\u20132055 (2012).","journal-title":"Int J Cancer"},{"key":"BFsrep11345_CR18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ccr.2008.09.001","volume":"14","author":"RH Wang","year":"2008","unstructured":"Wang, R. H. et al. Impaired DNA damage response, genome instability and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14, 312\u2013323 (2008).","journal-title":"Cancer Cell"},{"key":"BFsrep11345_CR19","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1016\/j.bmc.2009.07.001","volume":"17","author":"T Suzuki","year":"2009","unstructured":"Suzuki, T. et al. Design, synthesis, enzyme inhibition and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors. Bioorg Med Chem 17, 5900\u20135905 (2009).","journal-title":"Bioorg Med Chem"},{"key":"BFsrep11345_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-60327-409-8_9","volume":"682","author":"Z Darzynkiewicz","year":"2011","unstructured":"Darzynkiewicz, Z., Pozarowski, P., Lee, B. W. & Johnson, G. L. Fluorochrome-labeled inhibitors of caspases: convenient in vitro and in vivo markers of apoptotic cells for cytometric analysis. Methods Mol Biol 682, 103\u2013114 (2011).","journal-title":"Methods Mol Biol"},{"key":"BFsrep11345_CR21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymeth.2013.03.020","volume":"61","author":"ME Christensen","year":"2013","unstructured":"Christensen, M. E., Jansen, E. S., Sanchez, W. & Waterhouse, N. J. Flow cytometry based assays for the measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release. Methods 61, 138\u2013145 (2013).","journal-title":"Methods"},{"key":"BFsrep11345_CR22","doi-asserted-by":"crossref","first-page":"e6611","DOI":"10.1371\/journal.pone.0006611","volume":"4","author":"H Kang","year":"2009","unstructured":"Kang, H., Jung, J. W., Kim, M. K. & Chung, J. H. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One 4, e6611 (2009).","journal-title":"PLoS One"},{"key":"BFsrep11345_CR23","first-page":"2360","volume":"93","author":"N Mori","year":"1999","unstructured":"Mori, N. et al. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93, 2360\u20132368 (1999).","journal-title":"Blood"},{"key":"BFsrep11345_CR24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309\u20131312 (1998).","journal-title":"Science"},{"key":"BFsrep11345_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","volume":"157","author":"DR Green","year":"2014","unstructured":"Green, D. R. & Levine, B. To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate. Cell 157, 65\u201375 (2014).","journal-title":"Cell"},{"key":"BFsrep11345_CR26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait, S. W. & Green, D. R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621\u2013632 (2010).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep11345_CR27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nm1263","volume":"11","author":"G Kroemer","year":"2005","unstructured":"Kroemer, G. & Martin, S. J. Caspase-independent cell death. Nat Med 11, 725\u2013730 (2005).","journal-title":"Nat Med"},{"key":"BFsrep11345_CR28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4161\/auto.21028","volume":"8","author":"LL Chan","year":"2012","unstructured":"Chan, L. L. et al. A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8, 1371\u20131382 (2012).","journal-title":"Autophagy"},{"key":"BFsrep11345_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc2562","volume":"9","author":"CL Brooks","year":"2009","unstructured":"Brooks, C. L. & Gu, W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9, 123\u2013128 (2009).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep11345_CR30","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-08-3365","volume":"69","author":"T Liu","year":"2009","unstructured":"Liu, T., Liu, P. Y. & Marshall, G. M. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69, 1702\u20131705 (2009).","journal-title":"Cancer Res"},{"key":"BFsrep11345_CR31","doi-asserted-by":"crossref","first-page":"e4020","DOI":"10.1371\/journal.pone.0004020","volume":"3","author":"T Sasaki","year":"2008","unstructured":"Sasaki, T. et al. Phosphorylation regulates SIRT1 function. PLoS One 3, e4020 (2008).","journal-title":"PLoS One"},{"key":"BFsrep11345_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2443.2010.01460.x","volume":"16","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 16, 34\u201345 (2011).","journal-title":"Genes Cells"},{"key":"BFsrep11345_CR33","doi-asserted-by":"crossref","first-page":"20295","DOI":"10.3390\/molecules191220295","volume":"19","author":"T Kozako","year":"2014","unstructured":"Kozako, T. et al. Anticancer Agents Targeted to Sirtuins. Molecules 19, 20295\u201320313 (2014).","journal-title":"Molecules"},{"key":"BFsrep11345_CR34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ceb.2004.09.008","volume":"16","author":"C Garrido","year":"2004","unstructured":"Garrido, C. & Kroemer, G. Life\u2019s smile, death\u2019s grin: vital functions of apoptosis-executing proteins. Curr Opin Cell Biol 16, 639\u2013646 (2004).","journal-title":"Curr Opin Cell Biol"},{"key":"BFsrep11345_CR35","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI26390","volume":"115","author":"B Levine","year":"2005","unstructured":"Levine, B. & Yuan, J. Autophagy in cell death: an innocent convict? J Clin Invest 115, 2679\u20132688 (2005).","journal-title":"J Clin Invest"},{"key":"BFsrep11345_CR36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3892\/ijo.2012.1534","volume":"41","author":"J Wang","year":"2012","unstructured":"Wang, J. et al. Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells. Int J Oncol 41, 1101\u20131109 (2012).","journal-title":"Int J Oncol"},{"key":"BFsrep11345_CR37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama, M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79, 428\u2013437 (1991).","journal-title":"Br J Haematol"},{"key":"BFsrep11345_CR38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.21985","volume":"83","author":"T Kozako","year":"2011","unstructured":"Kozako, T. et al. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. J Med Virol 83, 501\u2013509 (2011).","journal-title":"J Med Virol"},{"key":"BFsrep11345_CR39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.humimm.2011.07.308","volume":"72","author":"T Kozako","year":"2011","unstructured":"Kozako, T. et al. Programmed death-1 (PD-1)\/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy\/tropical spastic paraparesis and carriers with autoimmune disorders. Hum Immunol 72, 1001\u20131006 (2011).","journal-title":"Hum Immunol"},{"key":"BFsrep11345_CR40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exphem.2003.11.008","volume":"32","author":"N Arima","year":"2004","unstructured":"Arima, N. et al. HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells. Exp Hematol 32, 195\u2013201 (2004).","journal-title":"Exp Hematol"},{"key":"BFsrep11345_CR41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi, I. et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294, 770\u2013771 (1981).","journal-title":"Nature"},{"key":"BFsrep11345_CR42","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/ijc.23860","volume":"123","author":"C Ishikawa","year":"2008","unstructured":"Ishikawa, C. et al. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int J Cancer 123, 2702\u20132712 (2008).","journal-title":"Int J Cancer"},{"key":"BFsrep11345_CR43","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1742-4658.2011.08055.x","volume":"278","author":"T Kozako","year":"2011","unstructured":"Kozako, T. et al. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS J 278, 1358\u20131366 (2011).","journal-title":"FEBS J"},{"key":"BFsrep11345_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cyto.a.10074","volume":"55","author":"P Pozarowski","year":"2003","unstructured":"Pozarowski, P. et al. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation. Cytometry A 55, 50\u201360 (2003).","journal-title":"Cytometry A"},{"key":"BFsrep11345_CR45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","volume":"103","author":"D Wlodkowic","year":"2011","unstructured":"Wlodkowic, D., Telford, W., Skommer, J. & Darzynkiewicz, Z. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol 103, 55\u201398 (2011).","journal-title":"Methods Cell Biol"},{"key":"BFsrep11345_CR46","doi-asserted-by":"crossref","unstructured":"Puleston, D. J. et al. Autophagy is a critical regulator of memory CD8(+) T cell formation. Elife 3 10.7554\/eLife.03706 (2014).","DOI":"10.7554\/eLife.03706"},{"key":"BFsrep11345_CR47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/leu.2013.264","volume":"28","author":"MV Stankov","year":"2014","unstructured":"Stankov, M. V. et al. Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia 28, 577\u2013588 (2014).","journal-title":"Leukemia"},{"key":"BFsrep11345_CR48","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.febslet.2008.12.063","volume":"583","author":"T Fujimoto","year":"2009","unstructured":"Fujimoto, T. et al. ZFAT is an antiapoptotic molecule and critical for cell survival in MOLT-4 cells. FEBS Lett 583, 568\u2013572 (2009).","journal-title":"FEBS Lett"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep11345","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep11345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep11345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T18:03:05Z","timestamp":1672941785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep11345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,9,1]]}},"alternative-id":["BFsrep11345"],"URL":"https:\/\/doi.org\/10.1038\/srep11345","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,19]]},"assertion":[{"value":"30 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11345"}}